Compare Alcon AG (ALC) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs MINISO Group Holding Ltd — how do they compare? Alcon AG trades at $66.79 (market cap $32.69B), while MINISO Group Holding Ltd trades at $11.81 (market cap $3.52B). The key difference: Alcon AG is far larger — about 9.3× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays the higher dividend (5.69%). Which is the better fit depends on your goals.
| ALC | MNSO | |
|---|---|---|
Market Cap | $32.69B | $3.52B |
Sector | Health | Technology |
52-Week High | $92.22 | $26.63 |
52-Week Low | $62.02 | $11.30 |
Enterprise Value | $36.28B | $4.19B |
Dividend Yield | 0.54% | 5.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
MNSO trades at $11.90, up 1.54% today, with a bearish technical signal from moving averages and mixed oscillators. The company reported strong Q1 2026 earnings that beat expectations, with revenue growth of 28.5% year-over-year, and announced a HK$2 billion share repurchase program on June 29, 2026. Valuation ratios appear reasonable with a P/E of 12.11 and P/S of 1.1, while profitability metrics show a net income margin of 8.98% and ROE of 18.88%.
The outlook is cautiously optimistic given earnings momentum and shareholder-friendly actions, but risks include margin pressure from rising expenses and competitive threats. Analyst sentiment is positive with 75% buy ratings, though technical indicators suggest near-term resistance. Investors should weigh solid fundamentals against bearish price trends for entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
